Rikuto Christopher Shinohara, Shuhei Ishikawa, Risa Matsumoto, Koki Ito, Mariko Tonosaki, Shiina Matsuyama, Masahiro Ohgidani, Minori Koga, Naoki Hashimoto, Ichiro Kusumi, Takahiro A Kato
{"title":"Low-dose LPS and acute restraint stress attenuate behavioural sensitisation in methamphetamine-sensitised male mice.","authors":"Rikuto Christopher Shinohara, Shuhei Ishikawa, Risa Matsumoto, Koki Ito, Mariko Tonosaki, Shiina Matsuyama, Masahiro Ohgidani, Minori Koga, Naoki Hashimoto, Ichiro Kusumi, Takahiro A Kato","doi":"10.1111/bph.70697","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Clinical observations suggest that acute inflammatory states transiently modulate psychotic symptoms. However, animal models often use relatively strong inflammatory stimuli, and the effects of low-intensity acute inflammation on psychostimulant-induced behavioural sensitisation remain unclear.</p><p><strong>Experimental approach: </strong>We examined whether relatively low-intensity acute inflammatory stimuli attenuate behavioural sensitisation in methamphetamine (METH)-sensitised male mice, a model of psychostimulant-induced psychosis. We used a repeated METH (1 mg·kg<sup>-1</sup>)-sensitised model to evaluate the effects of acute inflammation on behavioural sensitisation. Acute inflammation was induced via two methods: lipopolysaccharides (LPS; 1 μg·kg<sup>-1</sup>) to mimic peripheral immune activation and restraint stress (RS; single 2-h exposure) to induce an acute stress-related neuroimmune response. LPS doses were adjusted with reference to the magnitude of peripheral cytokine elevation reported in patients, and RS was applied in short single sessions to avoid excessive inflammation.</p><p><strong>Key results: </strong>LPS and RS significantly attenuated behavioural sensitisation, without inducing other detectable behavioural abnormalities. The behavioural effects of both LPS and RS were sensitive to toll-like receptor 4 (TLR4) inhibition. LPS-mediated attenuation was sensitive to cyclooxygenase-2 (COX-2) inhibition, whereas RS-mediated attenuation involved tumour necrosis factor-α (TNF-α). TNF-α expression was increased in brain-isolated microglia following RS, and intrastriatal TNF-α reproduced the attenuation of behavioural sensitisation. RS, but not LPS, significantly reduced the striatal extracellular dopamine levels.</p><p><strong>Conclusions and implications: </strong>Acute inflammation attenuated METH-induced behavioural sensitisation following low-dose LPS and acute RS. These findings suggest that acute inflammation may modulate processes relevant to METH-induced psychosis and highlight TNF-α as a candidate for further investigation.</p>","PeriodicalId":9262,"journal":{"name":"British Journal of Pharmacology","volume":" ","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bph.70697","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose: Clinical observations suggest that acute inflammatory states transiently modulate psychotic symptoms. However, animal models often use relatively strong inflammatory stimuli, and the effects of low-intensity acute inflammation on psychostimulant-induced behavioural sensitisation remain unclear.
Experimental approach: We examined whether relatively low-intensity acute inflammatory stimuli attenuate behavioural sensitisation in methamphetamine (METH)-sensitised male mice, a model of psychostimulant-induced psychosis. We used a repeated METH (1 mg·kg-1)-sensitised model to evaluate the effects of acute inflammation on behavioural sensitisation. Acute inflammation was induced via two methods: lipopolysaccharides (LPS; 1 μg·kg-1) to mimic peripheral immune activation and restraint stress (RS; single 2-h exposure) to induce an acute stress-related neuroimmune response. LPS doses were adjusted with reference to the magnitude of peripheral cytokine elevation reported in patients, and RS was applied in short single sessions to avoid excessive inflammation.
Key results: LPS and RS significantly attenuated behavioural sensitisation, without inducing other detectable behavioural abnormalities. The behavioural effects of both LPS and RS were sensitive to toll-like receptor 4 (TLR4) inhibition. LPS-mediated attenuation was sensitive to cyclooxygenase-2 (COX-2) inhibition, whereas RS-mediated attenuation involved tumour necrosis factor-α (TNF-α). TNF-α expression was increased in brain-isolated microglia following RS, and intrastriatal TNF-α reproduced the attenuation of behavioural sensitisation. RS, but not LPS, significantly reduced the striatal extracellular dopamine levels.
Conclusions and implications: Acute inflammation attenuated METH-induced behavioural sensitisation following low-dose LPS and acute RS. These findings suggest that acute inflammation may modulate processes relevant to METH-induced psychosis and highlight TNF-α as a candidate for further investigation.
期刊介绍:
The British Journal of Pharmacology (BJP) is a biomedical science journal offering comprehensive international coverage of experimental and translational pharmacology. It publishes original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor, and commentaries.
Review articles, databases, systematic reviews, and meta-analyses are typically commissioned, but unsolicited contributions are also considered, either as standalone papers or part of themed issues.
In addition to basic science research, BJP features translational pharmacology research, including proof-of-concept and early mechanistic studies in humans. While it generally does not publish first-in-man phase I studies or phase IIb, III, or IV studies, exceptions may be made under certain circumstances, particularly if results are combined with preclinical studies.